ERSP Refers NVE Pharmaceuticals’ AppuLoss Weight-Loss Ads To FTC

The Electronic Retailing Self-Regulation Program referred advertising for NVE Pharmaceuticals' AppuLoss dietary supplement to the Federal Trade Commission after the firm failed to respond to an inquiry

More from Archive

More from Pink Sheet